Non-Alcoholic Fatty Liver Disease (NAFLD)

Key Takeaways

NAFLD involves fat buildup in the liver not caused by alcohol.
Commonly associated with obesity, insulin resistance, and metabolic syndrome.
NAFLD can lead to severe liver conditions like non-alcoholic steatohepatitis (NASH) and cirrhosis if untreated.
Diet rich in nutrient-dense foods, along with regular physical activity, is key to managing and preventing NAFLD.
Early detection and intervention are important to prevent progression to more serious liver diseases.

What is Non-Alcoholic Fatty Liver Disease?

Non-Alcoholic Fatty Liver Disease (NAFLD)

Definition of NAFLD

NAFLD is characterized by excessive fat buildup in the liver cells, accounting for more than 5-10% of the liver’s weight, without significant alcohol consumption.

It is increasingly common, particularly in people who are overweight, have type 2 diabetes, or suffer from metabolic syndrome.

NAFLD can progress from simple fat accumulation in the liver to more severe conditions that damage liver function.

Stages of NAFLD

Simple Fatty Liver (Steatosis): This stage involves the accumulation of fat in the liver cells without significant inflammation or liver damage.
Non-Alcoholic Steatohepatitis (NASH): This more advanced stage is marked by liver inflammation and cell damage, which can lead to fibrosis (scarring) of the liver.
Fibrosis and Cirrhosis: Prolonged inflammation and liver damage can result in fibrosis and, eventually, cirrhosis, which significantly impairs liver function and may lead to liver failure.

Causes and Risk Factors

Obesity and Overweight

Excess body fat, particularly around the abdomen, is strongly linked to NAFLD. Obesity increases the likelihood of fat being deposited in the liver.

Insulin Resistance and Type 2 Diabetes

Insulin resistance, commonly seen in type 2 diabetes, promotes fat accumulation in the liver and is a major risk factor for NAFLD.

Metabolic Syndrome

Metabolic syndrome, which includes conditions such as high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels, significantly increases the risk of developing NAFLD.

Genetic Factors

Genetics may also influence the development of NAFLD, making some individuals more susceptible to the condition.

Poor Diet and Sedentary Lifestyle

A diet high in carbohydrates and ultra-processed foods, combined with a lack of physical activity, contributes to fat buildup in the liver.

Fructose, especially from high-fructose corn syrup (HFCS), contributes significantly to the development of NAFLD by promoting de novo lipogenesis (DNL) and increasing triglyceride accumulation in the liver.

Unlike glucose, fructose metabolism bypasses key regulatory steps, leading to rapid fat synthesis, oxidative stress, and inflammatory responses in the liver.

Excessive fructose intake is linked to the progression of liver damage, including fibrosis, through mechanisms involving increased uric acid levels, ATP depletion, and endoplasmic reticulum stress.

Symptoms of NAFLD

Early Stages (Steatosis)

NAFLD often does not cause noticeable symptoms in its early stages. Many individuals with simple fatty liver are unaware they have the condition.

Advanced Stages (NASH and Cirrhosis)

As NAFLD progresses, symptoms may include fatigue, weakness, weight loss, and discomfort in the upper right abdomen.

Advanced liver damage can lead to jaundice (yellowing of the skin and eyes), swelling in the abdomen and legs, and mental confusion.

Diagnosis of NAFLD

Blood Tests (Liver Enzymes)

Elevated liver enzyme levels in blood tests can indicate liver inflammation or damage, which may suggest the presence of NAFLD.

Imaging Tests (Ultrasound, MRI)

Imaging tests like ultrasounds or MRIs can detect fat accumulation in the liver, helping to confirm a diagnosis of NAFLD.

Liver Biopsy

In some cases, a liver biopsy might be needed to determine the extent of liver damage and to distinguish between simple fatty liver and NASH.

Treatment and Management of NAFLD

Lifestyle Changes

Diet:

Avoid grains, sugars, and processed foods, which contribute to liver fat accumulation.
Emphasize a diet rich in bio-available foods, such as grass-fed ruminant red meat and organs, pasture-raised eggs, and wild-caught seafood.
Include healthy animal fats like ghee, butter, and tallow.

Exercise:

Regular physical activity is important.
Aim for at least 150 minutes of moderate-intensity exercise per week to help reduce liver fat and improve overall metabolic health.

Weight Loss:

Gradual and sustained weight loss can significantly reduce liver fat and inflammation, lowering the risk of progression to more severe liver disease.

Medications and Medical Interventions

Currently, there are no specific medications approved for treating NAFLD. However, managing conditions like diabetes, and insulin resistance may help reduce the risk of liver damage.

Lifestyle changes remain the most effective treatment.

Monitoring and Follow-Up

Regular monitoring of liver function through blood tests and imaging is essential for tracking the progression of NAFLD and adjusting treatment as needed.

Prevention of NAFLD

Healthy Habits to Maintain While Traveling

Healthy Diet

A diet focused on bioavailable nutrient-dense whole foods while avoiding grains, sugars, and ultra-processed foods can help prevent the development of NAFLD.

Regular Physical Activity

Maintaining a regular exercise routine helps prevent fat buildup in the liver and supports overall health.

Weight Management

Keeping a healthy weight through proper diet and exercise is key to preventing NAFLD.

Potential Complications

Progression to NASH

If left untreated, simple fatty liver can progress to NASH, leading to more severe liver inflammation and damage.

Fibrosis and Cirrhosis

Chronic liver inflammation can lead to fibrosis (scarring) and eventually cirrhosis, which severely impairs liver function and can lead to liver failure.

Increased Risk of Cardiovascular Disease

NAFLD is associated with a higher risk of cardiovascular diseases due to its links with obesity, insulin resistance, and metabolic syndrome.

Conclusion

Non-Alcoholic Fatty Liver Disease is a common but potentially serious condition that can progress to severe liver damage if not managed properly. A diet rich in animal-based foods, combined with regular physical activity and weight management, is the most effective way to treat and prevent NAFLD. Early diagnosis and intervention are critical to preventing the progression to more serious liver conditions.

FAQs

What causes non-alcoholic fatty liver disease?

NAFLD is primarily caused by obesity, insulin resistance, and poor dietary habits, leading to fat accumulation in the liver.

Can NAFLD be reversed?

Yes, NAFLD can often be reversed through dietary changes, regular exercise, and sustained weight loss.

What is the difference between NAFLD and NASH?

NAFLD involves fat buildup in the liver, while NASH includes inflammation and liver cell damage, which can lead to more serious conditions like fibrosis and cirrhosis.

How is NAFLD diagnosed?

NAFLD is diagnosed through blood tests, imaging studies like ultrasound or MRI, and sometimes a liver biopsy to assess the extent of liver damage.

What lifestyle changes can help manage NAFLD?

Adopting a diet rich in animal-based foods, engaging in regular physical activity, and achieving gradual weight loss are key to managing and preventing NAFLD.

Research



Ambreen, G., Siddiq, A., & Hussain, K. (2020). Association of long-term consumption of repeatedly heated mix vegetable oils in different doses and hepatic toxicity through fat accumulation. *Lipids in Health and Disease*, 19(1). https://doi.org/10.1186/s12944-020-01256-0.

Anderson, E.L., Howe, L.D., Jones, H.E., Higgins, J.P.T., Lawlor, D.A., & Fraser, A. (2015). The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis. *PLOS ONE*, 10(10), p.e0140908. https://doi.org/10.1371/journal.pone.0140908.

Asrih, M., & Jornayvaz, F. R. (2014). Diets and nonalcoholic fatty liver disease: The good and the bad. Clinical Nutrition, 33(2), 186-190. 
https://doi.org/10.1016/j.clnu.2013.11.003

Basaranoglu, M., Basaranoglu, G., Sabuncu, T., & Sentürk, H. (2013). Fructose as a key player in the development of fatty liver disease. *World Journal of Gastroenterology*, 19(8), 1166-1172. https://doi.org/10.3748/wjg.v19.i8.1166.

Chen, H.L., Tsai, T.C., Tsai, Y.C., Liao, J.W., Yen, C.C., & Chen, C.M. (2016). Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway. *Nutrition & Diabetes*, 6(12), pp.e237. https://doi.org/10.1038/nutd.2016.49.

Coronati, M., Baratta, F., Pastori, D., Ferro, D., Angelico, F., & Del Ben, M. (2022). Added fructose in non-alcoholic fatty liver disease and in metabolic syndrome: A narrative review. *Nutrients*, 14(6), p.1127. https://doi.org/10.3390/nu14061127.

D’Abbondanza, M., Ministrini, S., Pucci, G., Nulli Migliola, E., Martorelli, E.-E., Gandolfo, V., Siepi, D., Lupattelli, G., & Vaudo, G. (2020). Very low-carbohydrate ketogenic diet for the treatment of severe obesity and associated non-alcoholic fatty liver disease: The role of sex differences. *Nutrients*, 12(9), p.2748. https://doi.org/10.3390/nu12092748.

D., J., P., A., & F., J. Different dietary approaches, non-alcoholic fatty liver disease and cardiovascular disease: A literature review. *Nutrients*, 15(6), 1483. https://doi.org/10.3390/nu15061483.

Fan, G., & Cao, X. Role of diet and nutritional management in non-alcoholic fatty liver disease. *Journal of Gastroenterology and Hepatology*, 28, 81-87. https://doi.org/10.1111/jgh.12244.

Félix, D.R., Costenaro, F., Gottschall, C.B.A., & Coral, G.P. (2016). Non-alcoholic fatty liver disease (NAFLD) in obese children—effect of refined carbohydrates in diet. *BMC Pediatrics*, 16(1). https://doi.org/10.1186/s12887-016-0726-3.

Gopalakrishnan Ravikumar, N.P., Nallapeta, N.S., & Mahl, T. (2019). Risk of developing non-alcoholic fatty liver disease (NAFLD) with increased intake of high fructose corn syrup (HFCS): A systematic review. *American Journal of Gastroenterology*, 114(1), pp.S1615. https://doi.org/10.14309/01.ajg.0000601436.73048.30.

Goss, A.M., Dowla, S., Pendergrass, M., Ashraf, A., Bolding, M., Morrison, S., Amerson, A., Soleymani, T., & Gower, B. (2020). Effects of a carbohydrate‐restricted diet on hepatic lipid content in adolescents with non‐alcoholic fatty liver disease: A pilot, randomized trial. *Pediatric Obesity*, 15(7). https://doi.org/10.1111/ijpo.12630.

Grinshpan, L.S., Eilat-Adar, S., Ivancovsky-Wajcman, D., Kariv, R., Gillon-Keren, M., & Zelber-Sagi, S. (2024). Ultra-processed food consumption and non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance: A systematic review. *JHEP Reports*, 6(1), p.100964. https://doi.org/10.1016/j.jhepr.2023.100964.

Hägele, F.A., Enderle, J., Rimbach, G., & Bosy-Westphal, A. (2023). Ultra-processed food consumption and the risk of non-alcoholic fatty liver disease—What are the proposed mechanisms? *Exploration of Digestive Diseases*, 1(1), pp.133-148. https://doi.org/10.37349/edd.2023.00023.

Hydes, T., Alam, U., & Cuthbertson, D.J. (2021). The impact of macronutrient intake on non-alcoholic fatty liver disease (NAFLD): Too much fat, too much carbohydrate, or just too many calories? *Frontiers in Nutrition*, 8, 640557. https://doi.org/10.3389/fnut.2021.640557.

Ivancovsky‐Wajcman, D., Fliss‐Isakov, N., Webb, M., Bentov, I., Shibolet, O., Kariv, R., & Zelber‐Sagi, S. (2021). Ultra‐processed food is associated with features of metabolic syndrome and non‐alcoholic fatty liver disease. *Liver International*, 41(11), pp.2635–2645. https://doi.org/10.1111/liv.14996.

Jarvis, H., Craig, D., Barker, R., Spiers, G., Stow, D., Anstee, Q.M., & Hanratty, B. (2020). Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies. *PLOS Medicine*, 17(4), p.e1003100. https://doi.org/10.1371/journal.pmed.1003100.

Keating, S. E., Hackett, D. A., George, J., & Johnson, N. A. (2012). Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis. *Journal of Hepatology*, 57(1), 157-166. https://doi.org/10.1016/j.jhep.2012.02.023.

Konieczna, J., Fiol, M., Colom, A., Ángel, M., Corella, D., Trinidad, M., Martínez, J. A., M., Á., Wärnberg, J., Vioque, J., Estruch, R., Rosa, M., Lapetra, J., Tur, J. A., Martín Sánchez, V., Pintó, X., Gaforio, J. J., Vidal, J., Vázquez, C., . . . Romaguera, D. (2022). Does consumption of ultra-processed foods matter for liver health? Prospective analysis among older adults with metabolic syndrome. *Nutrients*, 14(19), p.4142. https://doi.org/10.3390/nu14194142.

Liu, Z., Huang, H., Zeng, Y., Chen, Y., & Xu, C. (2022). Association between ultra-processed foods consumption and risk of non-alcoholic fatty liver disease: a population-based analysis of NHANES 2011–2018. *British Journal of Nutrition*, 130(6), pp.996–1004. https://doi.org/10.1017/s0007114522003956.

Luukkonen, P. K., Dufour, S., Lyu, K., Zhang, X., Hakkarainen, A., Lehtimäki, T. E., Cline, G. W., Petersen, K. F., & Shulman, G. I. (2020). Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease. *Proceedings of the National Academy of Sciences*, 117(13), 7347-7354. https://doi.org/10.1073/pnas.1922344117.

Luukkonen, P. K., Hodson, L., & Moore, J. B. (2021). Dietary carbohydrates and fats in nonalcoholic fatty liver disease. *Nature Reviews Gastroenterology & Hepatology*, 18(11), 770-786. https://doi.org/10.1038/s41575-021-00472-y.

Marchesini, G., Brizi, M., Morselli-Labate, A.M., Bianchi, G., Bugianesi, E., McCullough, A.J., Forlani, G., & Melchionda, N. (1999). Association of nonalcoholic fatty liver disease with insulin resistance. *The American Journal of Medicine*, 107(5), pp.450–455. https://doi.org/10.1016/s0002-9343(99)00271-5.

Musso, G., Gambino, R., Tabibian, J.H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S.K., Charatcharoenwitthaya, P., George, J., Barrera, F., Hafliðadóttir, S., Björnsson, E.S., Armstrong, M.J., Hopkins, L.J., Gao, X., Francque, S., Verrijken, A., Yilmaz, Y., Lindor, K.D., Charlton, M., Haring, R., Lerch, M.M., Rettig, R., Völzke, H., Ryu, S., Li, G., Wong, L.L., Machado, M., Cortez-Pinto, H., Yasui, K., & Cassader, M. (2014). Association of non-alcoholic fatty liver disease with chronic kidney disease: A systematic review and meta-analysis. *PLoS Medicine*, 11(7), p.e1001680. https://doi.org/10.1371/journal.pmed.1001680.

Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008). Fructose consumption as a risk factor for non-alcoholic fatty liver disease. *Journal of Hepatology*, 48(6), 993-999. https://doi.org/10.1016/j.jhep.2008.02.011.

Pai, S.A., Munshi, R.P., & Juvekar, A.R. (2019). Partially hydrogenated vegetable oil containing 5% trans fats when combined with fructose exacerbates obesity and non-alcoholic fatty liver disease in rats. *Nutrire*, 45(1). https://doi.org/10.1186/s41110-019-0105-6.

Papadopoulos, G., Legaki, A.-I., Georgila, K., Vorkas, P., Giannousi, E., Stamatakis, G., Moustakas, I.I., Petrocheilou, M., Pyrina, I., Gercken, B., Kassi, E., Chavakis, T., Pateras, I.S., Panayotou, G., Gika, H., Samiotaki, M., Eliopoulos, A.G., & Chatzigeorgiou, A. (2023). Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity. *Metabolism*, 144, p.155552. https://doi.org/10.1016/j.metabol.2023.155552.

Park, G., Jung, S., Wellen, K. E., & Jang, C. (2021). The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease. Experimental & Molecular Medicine, 53(5), 809-822. 
https://doi.org/10.1038/s12276-021-00614-x

Targher, G., Byrne, C.D., Lonardo, A., Zoppini, G., & Barbui, C. (2016). Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. *Journal of Hepatology*, 65(3), pp.589–600. https://doi.org/10.1016/j.jhep.2016.05.013.

Watanabe, M., Tozzi, R., Risi, R., Tuccinardi, D., Mariani, S., Basciani, S., Spera, G., Lubrano, C., & Gnessi, L. (2020). Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature. Obesity Reviews, 21(8), e13024. 
https://doi.org/10.1111/obr.13024

Ye, Q., Zou, B., Yeo, Y.H., Li, J., Huang, D.Q., Wu, Y., Yang, H., Liu, C., Kam, L.Y., Tan, X.X.E., Chien, N., Trinh, S., Henry, L., Stave, C.D., Hosaka, T., Cheung, R.C., & Nguyen, M.H. (2020). Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. *The Lancet Gastroenterology & Hepatology*, 5(8), pp.739–752. https://doi.org/10.1016/s2468-1253(20)30077-7.

Yki-Järvinen, H. (2015). Nutritional modulation of non-alcoholic fatty liver disease and insulin resistance. *Nutrients*, 7(11), pp.9127–9138. https://doi.org/10.3390/nu7115454.

Zhang, S., Gan, S., Zhang, Q., Liu, L., Meng, G., Yao, Z., Wu, H., Gu, Y., Wang, Y., Zhang, T., Wang, X., Sun, S., Wang, X., Zhou, M., Jia, Q., Song, K., Qi, L., & Niu, K. (2021). Ultra-processed food consumption and the risk of non-alcoholic fatty liver disease in the Tianjin Chronic Low-grade Systemic Inflammation and Health Cohort Study. *International Journal of Epidemiology*, 51(1), pp.237–249. https://doi.org/10.1093/ije/dyab174.

Zhang, Y.-F., Qiao, W., Zhuang, J., Feng, H., Zhang, Z., & Zhang, Y. (2024). Association of ultra-processed food intake with severe non-alcoholic fatty liver disease: a prospective study of 143073 UK Biobank participants. *The Journal of Nutrition, Health and Aging*, 28(10), p.100352. https://doi.org/10.1016/j.jnha.2024.100352.

Zhao, L., Clay-Gilmour, A., Zhang, J., Zhang, X., & Steck, S. E. (2024). Higher ultra-processed food intake is associated with adverse liver outcomes: A prospective cohort study of UK Biobank participants. *The American Journal of Clinical Nutrition*, 119(1), 49-57. https://doi.org/10.1016/j.ajcnut.2023.10.014.

Zhao, L., Zhang, X., Martinez Steele, E., Lo, C.-H., Zhang, F.F., & Zhang, X. (2023). Higher ultra-processed food intake was positively associated with odds of NAFLD in both US adolescents and adults: A national survey. *Hepatology Communications*, 7(9). https://doi.org/10.1097/hc9.0000000000000240.